Growth through acquisitions BBK Worldwide joined Publicis Health in January 2022, signaling access to larger global networks, resources, and cross-sell opportunities across Publicis Health clients and platforms.

Innovative engagement platforms Launched TCN Engage in February 2023 to provide comprehensive visit support from initial inquiry to study completion, suggesting upsell potential around patient journey optimization, digital engagement tools, and analytics-enabled recruitment.

Diverse service suite BBK offers a wide range of patient recruitment and engagement services powered by TrialCentralNet, presenting cross-sell opportunities to sponsors seeking end-to-end patient experience improvements and DEI-focused enrollment strategies.

Balanced scale and focus With 51-200 employees and revenue in the $10M–$25M range, BBK sits in a sweet spot for mid-market pharma and biopharma sponsors looking for specialized, client-centric clinical trial marketing and patient services.

Technology-enabled capabilities Adopts modern tech stack (Node.js, Modernizr, DocuSign, HTTP/3) and is known for patented TrialCentralNet, indicating opportunities to offer integrations, data automation, and scalable digital workflows for trial recruitment and DEI tracking.